Vildagliptin: a novel DPP-4 inhibitor with pancreatic islet enhancement activity for treatment of patients with type 2 diabetes (Q36592144)

From Wikidata
Jump to navigation Jump to search
scientific article published on August 2006
edit
Language Label Description Also known as
English
Vildagliptin: a novel DPP-4 inhibitor with pancreatic islet enhancement activity for treatment of patients with type 2 diabetes
scientific article published on August 2006

    Statements

    Vildagliptin: a novel DPP-4 inhibitor with pancreatic islet enhancement activity for treatment of patients with type 2 diabetes (English)
    1 August 2006
    519-531

    Identifiers

     
    edit
      edit
        edit
          edit
            edit
              edit
                edit
                  edit
                    edit